Cargando…
Uncoupling RARA transcriptional activation and degradation clarifies the bases for APL response to therapies
In PML/RARA-driven acute promyelocytic leukemia (APL), retinoic acid (RA) induces leukemia cell differentiation and transiently clears the disease. Molecularly, RA activates PML/RARA-dependent transcription and also initiates its proteasome-mediated degradation. In contrast, arsenic, the other poten...
Autores principales: | Ablain, Julien, Leiva, Magdalena, Peres, Laurent, Fonsart, Julien, Anthony, Elodie, de Thé, Hugues |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3620357/ https://www.ncbi.nlm.nih.gov/pubmed/23509325 http://dx.doi.org/10.1084/jem.20122337 |
Ejemplares similares
-
Adefovir dipivoxil inhibits APL progression through degradation of the oncoprotein PML-RARA
por: Gong, Xubo, et al.
Publicado: (2022) -
SPRED1 deletion confers resistance to MAPK inhibition in melanoma
por: Ablain, Julien, et al.
Publicado: (2020) -
TTMV-RARA fusion as a recurrent cause of AML with APL characteristics
por: Sala-Torra, Olga, et al.
Publicado: (2022) -
Therapy-induced selective loss of leukemia-initiating activity in murine adult T cell leukemia
por: El Hajj, Hiba, et al.
Publicado: (2010) -
Coupling and Uncoupling of Tumor Immunity and Autoimmunity
por: Bowne, Wilbur B., et al.
Publicado: (1999)